WN

Wendy Naimark

Chief Technology Officer

Ripple Therapeutics

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Ripple Therapeutics
Industry
pharmaceuticals
Employees
31.0
Seniority
C suite
Annual Revenue
15000000.0
Total Funding
26800000.0
Latest Funding
Series A

Technologies

Outlook Microsoft Office 365 Amazon AWS Google Tag Manager Google Analytics Nginx Remote AI Micro Docker Splunk Data Analytics

Keywords

pharmaceutical manufacturing ophthalmic therapeutics sustained drug delivery controlled release prodrug technology zero-order release kinetics biodegradable implants dexamethasone delivery clinical trials implantable drug delivery retinal disease glaucoma management ocular hypertension treatment prodrug materials surface erosion drug dosing control pharmacokinetics safety profile tunable drug release micro & nanoparticles new treatment options drug delivery platform eye care partnership reduced treatment burden third-party evaluations regulatory path lower molecular weight high drug loading small implants long-term safety studies customizable drug therapies patient-centered care preclinical development intravitreal implants collaboration with abbvie biocompatibility minimalistic approach drug release profiles innovative therapeutic solutions clinical-stage company drug delivery devices preclinical pipeline ophthalmic technology expansion treatment algorithms eye disease therapies patented drug formulations pharmaceuticals medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans